TAM
LGND icon

Telemark Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Telemark Asset Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-240,450
Closed -$17.1M – 41
2019
Q2 		$17.1M Buy
+240,450
New +$17.7M 1.96% 21

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Telemark Asset Management's LGND Position: Q3 2019 in Review

Telemark Asset Management sold out of Ligand Pharmaceuticals (LGND) in Q3 2019, closing a stake of 240,450 shares — an estimated $17.1M sold.

Telemark Asset Management first reported a position in LGND in Q2 2019 and held it in 1 quarter. The position peaked at $17.1M in Q2 2019. 275 funds tracked by Wall St. Rank hold LGND as of Q3 2019.

  • Telemark Asset Management reported no remaining Ligand Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Telemark Asset Management sold 240,450 Ligand Pharmaceuticals shares in Q3 2019, an estimated $17.1M.
  • Telemark Asset Management first reported a position in Ligand Pharmaceuticals in Q2 2019 and held it in 1 quarter.
  • Telemark Asset Management's Ligand Pharmaceuticals position peaked at $17.1M in Q2 2019.
  • 275 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2019.

Based on Telemark Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.